We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.35%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+16.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$136B
AUM Growth
+$7.83B
Cap. Flow
+$9.38B
Cap. Flow %
6.92%
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,063
Increased
4,755
Reduced
3,911
Closed
1,116

Sector Composition

Rank Sector Weight
1 Energy 8.49%
2 Technology 6.67%
3 Healthcare 6.67%
4 Financials 6.58%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATML
3076
DELISTED
ATMEL CORP
ATML
$1.65M ﹤0.01%
204,399
+11,264
+6% +$97.4K
SLX icon
3077
VanEck Steel ETF
SLX
$176M
$1.65M ﹤0.01%
36,892
-1,527
-4% -$74.3K
JCP
3078
PUT
DELISTED
J.C. Penney Company, Inc.
JCP
$1.65M ﹤0.01%
164,100
-290,000
-64% -$2.84M
ICA
3079
DELISTED
EMPRESAS ICA, S.A. DE C.V. ADS (EA REPTG 4 ORD PART CERT)
ICA
$1.65M ﹤0.01%
238,153
+7,365
+3% +$54.9K
FANG icon
3080
Diamondback Energy
FANG
$55.7B
$1.65M ﹤0.01%
21,995
-19,374
-47% -$1.57M
KB icon
3081
KB Financial Group
KB
$42.4B
$1.65M ﹤0.01%
45,423
-4,144
-8% -$158K
TURN
3082
DELISTED
180 Degree Capital
TURN
$1.64M ﹤0.01%
183,908
-35,754
-16% -$341K
PALL icon
3083
abrdn Physical Palladium Shares ETF
PALL
$683M
$1.64M ﹤0.01%
109,250
-18,570
-15% -$311K
GTIP
3084
DELISTED
ISHARES TR GLOBAL INFLATION LKD BD ETF
GTIP
$1.64M ﹤0.01%
32,473
+1,817
+6% +$94.6K
PVA
3085
DELISTED
PENN VIRGINIA CORP
PVA
$1.64M ﹤0.01%
128,938
+112,278
+674% +$1.58M
DEX
3086
DELISTED
DELAWARE ENHANCED GLOBAL DIVIDEND & INCOME FUND
DEX
$1.63M ﹤0.01%
135,883
+28,468
+27% +$358K
BHL
3087
DELISTED
Blackrock Defined Opp Crt Tr
BHL
$1.63M ﹤0.01%
121,599
+16,053
+15% +$222K
NTRI
3088
DELISTED
NutriSystem, Inc.
NTRI
$1.63M ﹤0.01%
105,969
+64,534
+156% +$1.07M
TECH icon
3089
Bio-Techne
TECH
$11.2B
$1.63M ﹤0.01%
69,608
-11,980
-15% -$281K
BIO icon
3090
Bio-Rad Laboratories Class A
BIO
$9.48B
$1.63M ﹤0.01%
14,336
-5,804
-29% -$688K
RGR icon
3091
Sturm, Ruger & Co
RGR
$594M
$1.62M ﹤0.01%
33,267
-24,162
-42% -$1.27M
SCHD icon
3092
Schwab US Dividend Equity ETF
SCHD
$107B
$1.62M ﹤0.01%
126,072
+33,309
+36% +$428K
NIM icon
3093
Nuveen Select Maturities Municipal Fund
NIM
$116M
$1.62M ﹤0.01%
154,621
+14,016
+10% +$145K
GGG icon
3094
Graco
GGG
$13.5B
$1.62M ﹤0.01%
66,432
+15,789
+31% +$400K
CA
3095
CALL
DELISTED
CA, Inc.
CA
$1.61M ﹤0.01%
57,800
+38,100
+193% +$1.09M
PGZ
3096
Principal Real Estate Income Fund
PGZ
$68.4M
$1.61M ﹤0.01%
84,731
+15,267
+22% +$295K
STKL
3097
DELISTED
SunOpta
STKL
$1.61M ﹤0.01%
133,725
-14,175
-10% -$187K
RWW
3098
DELISTED
Invesco S&P Financials Revenue ETF
RWW
$1.61M ﹤0.01%
33,695
-14,675
-30% -$691K
KW
3099
CALL
DELISTED
Kennedy-Wilson Holdings
KW
$1.61M ﹤0.01%
67,100
+64,600
+2,584% +$1.63M
ACHN
3100
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
$1.61M ﹤0.01%
161,100
+126,200
+362% +$1.17M

Similar funds

UBS's Q3 2014 Portfolio in Review

As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS deployed $9.38B of net new capital in Q3 2014, opening 1,063 new positions and adding to 4,755 existing holdings. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M.

By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 8.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B trimmed.

  • UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
  • UBS added most to Amgen in Q3 2014, an estimated $387M increase.
  • UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
  • UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
  • UBS opened 1,063 new positions and closed 1,116 in Q3 2014.
  • UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.